<SEC-DOCUMENT>0001004878-17-000117.txt : 20170512
<SEC-HEADER>0001004878-17-000117.hdr.sgml : 20170512
<ACCEPTANCE-DATETIME>20170512172217
ACCESSION NUMBER:		0001004878-17-000117
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170512
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170512
DATE AS OF CHANGE:		20170512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		17839995

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8kitem801may-17.txt
<DESCRIPTION>FORM 8-K ITEM 8.01
<TEXT>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): May 12, 2017


                               CEL-SCI CORPORATION
                     -------------------------------------
             (Exact name of Registrant as specified in its charter)



      Colorado                         001-11889                 84-0916344
 --------------------             ------------------         -----------------
(State or other jurisdiction     (Commission File No.)      (IRS Employer
of incorporation)                                            Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                     -------------------------------------
          (Address of principal executive offices, including Zip Code)



      Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
                         ------------------------------
          (Former name or former address if changed since last report)

<PAGE>

Item 8.01   Other Events

     On May 12, 2017 the Company  issued a press  release,  filed as Exhibit 99,
regarding the  rescheduling  of its annual meeting of  shareholders  to June 12,
2017.



Item 9.01   Exhibits

Exhibit
Number     Description of Document
------     -----------------------

  99        May 12, 2017 Press Release.









                                       2
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  May 12, 2017                 CEL-SCI CORPORATION



                                    By: /s/ Patricia B. Prichep
                                       --------------------------------------
                                       Patricia B. Prichep
                                       Senior Vice President of Operations
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>form8kitem801ex99may-17.txt
<DESCRIPTION>EXHIBIT 99 PRTESS RELEASE
<TEXT>




                                   EXHIBIT 99




<PAGE>



8229 Boone Boulevard, Suite 802                                 COMPANY CONTACT:
Vienna, VA  22182.  USA                                           Gavin de Windt
Telephone (703) 506-9460                                     CEL-SCI Corporation
www.cel-sci.com                                                   (703) 506-9460

          CEL-SCI ANNOUNCES CHANGE TO THE DATE OF ITS ANNUAL MEETING

Vienna,  VA, Friday,  May 12, 2017 - CEL-SCI  Corporation  (NYSE MKT: CVM) today
announced  it has changed the date for its annual  meeting  from June 9, 2017 to
June 12, 2017.

The Company's annual meeting is now scheduled for Monday, June 12, 2017 at 10:30
a.m. local time. The meeting will be held at 4820-C Seton Drive,  Baltimore,  MD
21215.  No changes  have been made to the  record  date or the  proposals  to be
brought before the annual  meeting,  which are presented in the Proxy  Statement
that the Company  filed with the  Securities  and Exchange  Commission  (SEC) on
April  27,  2017.  Stockholders  who have  already  submitted  a proxy or voting
instructions do not need to take any further action.

The  Company's  Proxy  Statement and Annual Report filed by the Company with the
SEC are available on the SEC's website at http://www.sec.gov.

About CEL-SCI Corporation

CEL-SCI's  work is focused on finding the best way to activate the immune system
to fight cancer and infectious  diseases.  The Company has operations in Vienna,
Virginia, and in/near Baltimore, Maryland.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
